TITLE:
Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope

CONDITION:
Syncope

INTERVENTION:
midodrine

SUMMARY:

      OBJECTIVES:

      Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing
      neurally mediated syncope.
    

DETAILED DESCRIPTION:

      PROTOCOL OUTLINE: This is a randomized, double-blind, crossover, placebo-controlled study.

      On day one, patients receive either midodrine or placebo. On day three, patients receive the
      opposite drug.
    

ELIGIBILITY:
Gender: All
Age: 16 Years to N/A
Criteria:

        PROTOCOL ENTRY CRITERIA:

        --Disease Characteristics-- Diagnosis of neurally mediated syncope (vasovagal fainting)
        Sudden fall in blood pressure AND Slowing of the heart AND Temporary loss of consciousness
        AND Hemodynamic response to head up tilt --Prior/Concurrent Therapy-- No other concurrent
        adrenergic agonist or antiagonist --Patient Characteristics-- Fertile patients must use
        effective birth control
      
